ResearcherUniversity of California, Los AngelesNo recent work listed
Andrew Hieu Nguyen
Matched on ORCID iD 0000-0001-9746-6795; OpenAlex author ID A5101795805. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2014: 1 paper · 2015: 3 papers · 2016: 2 papers · 2017: 1 paper
Papers 7
- Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. Co-author DOI 10.18632/oncotarget.13572↗
- CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer. Co-author DOI 10.1007/s11605-016-3149-4↗
- Stiffness of pancreatic cancer cells is associated with increased invasive potential. Co-author DOI 10.1039/c6ib00135a↗
- Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease. First author DOI 10.1002/jso.24011↗
- p85α is a microRNA target and affects chemosensitivity in pancreatic cancer. Co-author DOI 10.1016/j.jss.2015.02.071↗
- Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition. Co-author DOI 10.1158/1078-0432.ccr-14-0610↗
- Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer. First author DOI 10.1002/jso.23750↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Timothy R. Donahue · 7 shared papers, 2014–2017 · strength 0.37
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. DOI 10.18632/oncotarget.13572↗
- Paper Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epi… DOI 10.1158/1078-0432.ccr-14-0610↗
- David W. Dawson · 4 shared papers, 2015–2017 · strength 0.21
- Paper Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. DOI 10.18632/oncotarget.13572↗
- Paper Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epi… DOI 10.1158/1078-0432.ccr-14-0610↗
- Paper Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with no… DOI 10.1002/jso.24011↗
- Paul A. Toste · 4 shared papers, 2014–2017 · strength 0.21
- Paper Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. DOI 10.18632/oncotarget.13572↗
- Paper Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epi… DOI 10.1158/1078-0432.ccr-14-0610↗
- Paper p85α is a microRNA target and affects chemosensitivity in pancreatic cancer. DOI 10.1016/j.jss.2015.02.071↗
- Brian E. Kadera · 3 shared papers, 2015–2016 · strength 0.17
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epi… DOI 10.1158/1078-0432.ccr-14-0610↗
- Paper p85α is a microRNA target and affects chemosensitivity in pancreatic cancer. DOI 10.1016/j.jss.2015.02.071↗
- Zev A. Wainberg · 2 shared papers, 2015–2016 · strength 0.11
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with no… DOI 10.1002/jso.24011↗
- Howard A. Reber · 2 shared papers, 2015–2016 · strength 0.11
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with no… DOI 10.1002/jso.24011↗
- Jennifer L. Williams · 2 shared papers, 2015–2016 · strength 0.11
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with no… DOI 10.1002/jso.24011↗
- V. Raman Muthusamy · 2 shared papers, 2015–2016 · strength 0.11
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with no… DOI 10.1002/jso.24011↗
- Oscar Joe Hines · 2 shared papers, 2015–2016 · strength 0.11
- Paper CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancr… DOI 10.1007/s11605-016-3149-4↗
- Paper Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with no… DOI 10.1002/jso.24011↗
- Irmina A. Elliott · 1 shared paper, 2017 · strength 0.06
- Razmik Ghukasyan · 1 shared paper, 2017 · strength 0.06
- Caius Gabriel Radu · 1 shared paper, 2017 · strength 0.06
- Angelyn V. Nguyen · 1 shared paper, 2016 · strength 0.05
- Amy C. Rowat · 1 shared paper, 2016 · strength 0.05
- David L. Madnick · 1 shared paper, 2015 · strength 0.05
- Matthew M. Rochefort · 1 shared paper, 2015 · strength 0.05
- James S. Tomlinson · 1 shared paper, 2015 · strength 0.05
- James J. Farrell · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.